Abstract: Lamellar endoplasmic reticulum (ER) stress occurs in hyperinsulinemia-associated and sepsis-related laminitis. Adiponectin is associated with reduced laminitis risk and inhibits ER stress in other species. Objective: To induce ER stress in ex vivo equine lamellar cells using pharmacological agents. To determine whether co-treatment with adiponectin receptor agonists (ARAs) reduces ER stress. Methods: In vitro. Methods: Lamellar cells from n = 4-5 horses were treated with tunicamycin or thapsigargin (10-1000 nM) for 2-24 h. ER-stressed cells were co-treated with full-length adiponectin (FLA; 30-3000 ng/mL), globular adiponectin (gA; 30-3000 ng/mL), AdipoRon (2-50 μM), or AICAR (1 mM) for 24 h. Expression of binding immunological protein (BIP) and spliced X-box binding protein (sXBP1; two ER stress markers), ribosomal protein 6 (RPS6), and interleukin-6 and -8 was determined using qRT-PCR and western blotting. Results: BIP expression increased in a concentration- and time-dependent manner and was highest after 24 h treatment with 1000 nM tunicamycin (mRNA: mean [95% CI] log fold-change [FC] = 4.8 [3.7-5.9]; p < 0.001; protein: logFC = 3.3 [2.7-4.0]; p < 0.001). XBP1 splicing increased from 6% [4-8] (control) to a maximum of 89% [86-93] (p < 0.001). Thapsigargin induced similar responses. Interleukin-6 (2 h; maximum logFC = 3.1 [0.7-5.6]; p = 0.03) and interleukin-8 (24 h; maximum logFC = 5.4 [2.6-8.2]; p = 0.04) increased with both stressors. ER stress-induced BIP protein expression was decreased by AICAR (logFC = -2.0 [-5.1 to -1.1], p = 0.04) and AdipoRon (maximum logFC = -1.8 [-2.1 to -1.5]; p = 0.001; tunicamycin), and by FLA (logFC = -1.3 [-1.8 to -0.7]; p = 0.002), and gA (logFC = -1.2 [-1.9 to -0.5]; p = 0.004; thapsigargin). Tunicamycin-induced XBP1 splicing decreased with FLA and AdipoRon (maximum change = -11%; p = 0.01), and with all ARAs after thapsigargin treatment (maximum change = -46%; p < 0.001). Total RPS6 expression was decreased by gA, AdipoRon, and AICAR (maximum logFC = -0.9; p < 0.001; tunicamycin). AdipoRon reduced RPS6 phosphorylation (logFC = -1.4 [-3.6 to -0.7]; p = 0.02; tunicamycin). Conclusions: Mixed lamellar cell population, small sample size. Conclusions: ARAs reduced ER stress marker expression in ex vivo equine lamellar cells, suggesting potential for laminitis treatment and prevention.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Protective effects of adiponectin receptor agonists against equine lamellar endoplasmic reticulum stress
Overview of the Study
This study investigated how endoplasmic reticulum (ER) stress occurs in equine lamellar cells, which is relevant to laminitis, a painful hoof disease in horses.
Researchers tested if activating adiponectin receptors with specific agonists can reduce ER stress markers, suggesting a potential therapeutic strategy for laminitis.
Background
Laminitis: A hoof disease in horses often linked to hyperinsulinemia (high insulin levels) and sepsis.
ER stress: A cellular condition where the ER has trouble folding proteins properly, which contributes to disease processes.
Adiponectin: A hormone known to be protective against laminitis and can inhibit ER stress in species other than horses.
Study Objectives
To induce ER stress in isolated equine lamellar cells using pharmacological agents.
To determine whether adiponectin receptor agonists (ARAs) can reduce ER stress in these cells.
Methods
Sample: Lamellar cells isolated from 4-5 horses.
ER stress induction: Cells were treated with
Tunicamycin (10-1000 nM), a compound that disrupts protein folding causing ER stress.
Thapsigargin (10-1000 nM), which disturbs calcium balance triggering ER stress.
Treatment durations ranged from 2 to 24 hours.
Co-treatments: ER-stressed cells were treated for 24 hours with adiponectin receptor agonists:
Full-length adiponectin (FLA) at 30-3000 ng/mL
Globular adiponectin (gA) at 30-3000 ng/mL
AdipoRon (synthetic adiponectin receptor agonist) at 2-50 μM
AICAR (AMPK activator) at 1 mM
Outcome measures: Expression of ER stress markers and inflammatory cytokines were measured:
BIP (Binding immunoglobulin protein), an ER stress marker
sXBP1 (Spliced X-box binding protein 1), another ER stress marker reflecting ER stress response activation
RPS6 (Ribosomal protein S6), related to protein synthesis regulation
Interleukin-6 and Interleukin-8, markers of inflammation
Techniques used: quantitative RT-PCR and western blotting
Key Results
ER Stress Induction:
BIP expression increased with dose and duration of tunicamycin/thapsigargin treatment; highest after 24h with 1000 nM tunicamycin.
XBP1 splicing increased significantly, indicating ER stress activation (from 6% in controls to up to 89%).
Interleukin-6 and Interleukin-8 mRNA levels increased, confirming an inflammatory response accompanying ER stress.
Effects of Adiponectin Receptor Agonists (ARAs) on ER Stress:
AICAR and AdipoRon significantly reduced BIP protein expression induced by tunicamycin.
Full-length adiponectin and globular adiponectin reduced BIP expression induced by thapsigargin.
FLA and AdipoRon decreased tunicamycin-induced sXBP1 splicing; all ARAs reduced sXBP1 splicing after thapsigargin treatment.
Globular adiponectin, AdipoRon, and AICAR decreased total RPS6 expression after tunicamycin treatment.
AdipoRon also reduced phosphorylation of RPS6, an indicator of reduced protein synthesis activity linked to stress.
Conclusions and Implications
Adiponectin receptor agonists effectively reduced markers of ER stress in cultured equine lamellar cells.
This suggests a potential therapeutic role for ARAs in treating or preventing laminitis by targeting ER stress pathways.
Limitations include using a mixed population of lamellar cells and a small sample size from 4-5 horses, so further research is needed.
The findings support targeting cellular stress responses as a strategy to reduce laminitis risk and could pave the way for novel treatments.
Cite This Article
APA
Barnabé MA, Elliott J, Menzies-Gow NJ, Bailey SR, Bamford NJ, Chang YM, Gage MC.
(2026).
Protective effects of adiponectin receptor agonists against equine lamellar endoplasmic reticulum stress.
Equine Vet J.
https://doi.org/10.1002/evj.70195
Department of Comparative Biomedical Sciences, Royal Veterinary College, Hertfordshire, UK.
Elliott, Jonathan
Department of Comparative Biomedical Sciences, Royal Veterinary College, Hertfordshire, UK.
Menzies-Gow, Nicola J
Department of Clinical Sciences and Services, Royal Veterinary College, Hertfordshire, UK.
Bailey, Simon R
Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, Australia.
Bamford, Nicholas J
Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, Australia.
Chang, Yu-Mei
Department of Comparative Biomedical Sciences, Royal Veterinary College, Hertfordshire, UK.
Gage, Matthew C
Department of Comparative Biomedical Sciences, Royal Veterinary College, Hertfordshire, UK.
Grant Funding
Horserace Betting Levy Board
References
This article includes 82 references
Dern K, Burns TA, Watts MR, van Eps AW, Belknap JK. Influence of digital hypothermia on lamellar events related to IL‐6/gp130 signalling in equine sepsis‐related laminitis. Equine Vet J 2020;52:441–448.
Lane HE, Burns TA, Hegedus OC, Watts MR, Weber PS, Woltman KA. Lamellar events related to insulin‐like growth factor‐1 receptor signalling in two models relevant to endocrinopathic laminitis. Equine Vet J 2017;49:643–654.
Inoki K, Kim J, Guan KL. AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol 2012;52:381–400.
Ozcan U, Ozcan L, Yilmaz E, Düvel K, Sahin M, Manning BD. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 2008;29:541–551.
Lemmer IL, Willemsen N, Hilal N, Bartelt A. A guide to understanding endoplasmic reticulum stress in metabolic disorders. Mol Metab 2021;47:1–19.
Bachar‐Wikstrom E, Wikstrom JD, Ariav Y, Tirosh B, Kaiser N, Cerasi E. Stimulation of autophagy improves endoplasmic reticulum stress‐induced diabetes. Diabetes 2013;62:1227–1237.
Yin J, Gu L, Wang Y, Fan N, Ma Y, Peng Y. Rapamycin improves palmitate‐induced ER stress/NF B pathways associated with stimulating autophagy in adipocytes. Mediators Inflamm 2015;2015:1–12.
Yang F, Yang L, Wataya‐Kaneda M, Yoshimura T, Tanemura A, Katayama I. Uncoupling of ER/mitochondrial oxidative stress in mTORC1 hyperactivation‐associated skin hypopigmentation. J Investig Dermatol 2018;138:669–678.
Kim H, Moon SY, Kim JS, Baek CH, Kim M, Min JY. Activation of AMP‐activated protein kinase inhibits ER stress and renal fibrosis. Am J Physiol Renal Physiol 2015;308:226–236.
Lin Y, Jiang M, Chen W, Zhao T, Wei Y. Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomed Pharmacother 2019;118:1–10.
Khan S, Wang CH. ER stress in adipocytes and insulin resistance: mechanisms and significance (review). Mol Med Rep 2014;10:2234–2240.
Lee JH, Lee J. Endoplasmic reticulum (ER) stress and its role in pancreatic β‐cell dysfunction and senescence in type 2 diabetes. Int J Mol Sci 2022;23:4843.
Li W, Cao T, Luo C, Cai J, Zhou X, Xiao X. Crosstalk between ER stress, NLRP3 inflammasome, and inflammation. Appl Microbiol Biotechnol 2020;104:6129–6140.
Cassimeris L, Engiles JB, Galantino‐Homer H. Detection of endoplasmic reticulum stress and the unfolded protein response in naturally‐occurring endocrinopathic equine laminitis. BMC Vet Res 2019;15:1–16.
Menzies‐Gow NJ, Harris PA, Elliott J. Prospective cohort study evaluating risk factors for the development of pasture‐associated laminitis in the United Kingdom.. Equine Vet J 2017;49:300–306.
Knowles EJ, Elliott J, Harris PA, Chang YM, Menzies‐Gow NJ. Predictors of laminitis development in a cohort of nonlaminitic ponies.. Equine Vet J 2023;55:12–23.
Boddu NJ, Theus S, Luo S, Wei JY, Ranganathan G. Is the lack of adiponectin associated with increased ER/SR stress and inflammation in the heart?. Adipocyte 2014;3:10–18.
Liu Z, Gan L, Wu T, Feng F, Luo D, Gu H. Adiponectin reduces ER stress‐induced apoptosis through PPARα transcriptional regulation of ATF2 in mouse adipose.. Cell Death Dis 2016;7:7.
Hou Y, Wang XF, Lang ZQ, Jin YC, Fu JR, Xv XM. Adiponectin is protective against endoplasmic reticulum stress‐induced apoptosis of endothelial cells in sepsis.. Braz J Med Biol Res 2018;51:1–10.
Li S, Bao HG, Han L, Liu L, Wang X. Effects of adiponectin on mortality and its mechanism in a sepsis mouse model.. J Invest Surg 2012;25:214–219.
Liu L‐J, Xu M, Zhu J, Li N, Zhao XZ, Gao HM. Adiponectin alleviates liver injury in sepsis rats through AMPK/MTOR pathway.. Eur Rev Med Pharmacol Sci 2020;24:10745–10752.
Teoh H, Quan A, Bang KWA, Wang G, Lovren F, Vu V. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis‐related mortality.. Am J Physiol Endocrinol Metab 2008;295:E658–E664.
Hillenbrand A, Xu P, Zhou S, Blatz A, Weiss M, Hafner S. Circulating adipokine levels and prognostic value in septic patients.. J Inflamm 2016;13:1–7.
Wang H, Gao YX, Wu YN, Li C, Duan J. Association between plasma adiponectin levels and left ventricular systolic dysfunction in sepsis patients.. J Crit Care 2020;60:195–201.
Torrente C, Manzanilla EG, Bosch L, Villaverde C, Pastor J, Ruiz de Gopegui R. Adiponectin as a sepsis biomarker in dogs: diagnostic and prognostic value.. Vet Clin Pathol 2020;49:333–344.
Elliott J, Bailey SR. Consequences of adiponectin deficiency: can they be related to the pathophysiology of laminitis?. Equine Vet J 2023;55:346–349.
Elliott J, Bailey SR. A review of cellular and molecular mechanisms in endocrinopathic, sepsis‐related and supporting limb equine laminitis.. Equine Vet J 2023;55:350–375.
Roy MF, Kwong GPS, Lambert J, Massie S, Lockhart S. Prognostic value and development of a scoring system in horses with systemic inflammatory response syndrome.. J Vet Intern Med 2017;31:582–592.
Bertin FR, Reising A, Slovis NM, Constable PD, Taylor SD. Clinical and clinicopathological factors associated with survival in 44 horses with equine neorickettsiosis (potomac horse fever).. J Vet Intern Med 2013;27:1528–1534.
Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose‐regulated proteins.. Nature 1988;332:462–464.
Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.. Cell 2001;107:881–889.
Fatima MT, Hasan M, Abdelsalam SS, Sivaraman SK, el‐Gamal H, Zahid MA. Sestrin2 suppression aggravates oxidative stress and apoptosis in endothelial cells subjected to pharmacologically induced endoplasmic reticulum stress.. Eur J Pharmacol 2021;907:174247.
Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.. Nature 2003;423:762–769.
Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, Lodish HF. T‐cadherin is a receptor for hexameric and high‐molecular‐weight forms of Acrp30/adiponectin.. Proc Natl Acad Sci U S A 2004;101:10308–10313.
Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS. Adiponectin modulates inflammatory reactions via calreticulin receptor‐dependent clearance of early apoptotic bodies.. J Clin Investig 2007;117:375–386.
Zhang D, Guo M, Zhang W, Lu XY. Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen‐activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK‐3β)/β‐catenin signaling cascade.. J Biol Chem 2011;286:44913–44920.
Okada‐Iwabu M, Yamauchi T, Iwabu M, Honma T, Hamagami KI, Matsuda K. A small‐molecule AdipoR agonist for type 2 diabetes and short life in obesity.. Nature 2013;503:493–499.
Balasubramanian P, Schaar AE, Gustafson GE, Smith AB, Howell PR, Greenman A. Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice.. Elife 2022;11:11.
Wang SJ, Lu WY, Liu KY. Adiponectin receptor agonist AdipoRon suppresses adipogenesis in C3H10T1/2 cells through the adenosine monophosphate‐activated protein kinase signaling pathway.. Mol Med Rep 2017;16:7163–7169.
Samsonov MV, Podkuychenko NV, Khapchaev AY, Efremov EE, Yanushevskaya EV, Vlasik TN. Aicar protects vascular endothelial cells from oxidative injury induced by the long‐term palmitate excess.. Int J Mol Sci 2002;23:211.
Hildebrandt D, Venner M, Hart KA, Berghaus L. Plasma C‐reactive protein and interleukin‐6 concentrations in foals during health and respiratory disease.. Equine Vet J 2025;58:1–8.
Harriman JF, Liu XL, Aleo MD, Machaca K, Schnellmann RG. Endoplasmic reticulum Ca2+ signaling and calpains mediate renal cell death.. Cell Death Differ 2002;9:734–741.
Pick T, Gamayun I, Tinschert R, Cavalié A. Kinetics of the thapsigargin‐induced Ca2+ mobilisation: a quantitative analysis in the HEK‐293 cell line.. Front Physiol 2023;14:1127545.
Fernandez‐Fuente M, Terracciano CM, Martin‐Duque P, Brown SC, Vassaux G, Piercy RJ. Calcium homeostasis in myogenic differentiation factor 1 (MyoD)‐transformed, virally‐transduced, skin‐derived equine myotubes.. PLoS One 2014;9:e105971.
Fu S, Yang L, Li P, Hofmann O, Dicker L, Hide W, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 2011;473(7348):528–531.
Arruda AP, Hotamisligil GS. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab. 2015;22:381–397.
Guerrero‐Hernández A, Leon‐Aparicio D, Chavez‐Reyes J, Olivares‐Reyes JA, DeJesus S. Endoplasmic reticulum stress in insulin resistance and diabetes. Cell Calcium. 2014;56:311–322.
Ghemrawi R, Battaglia‐Hsu SF, Arnold C. Endoplasmic reticulum stress in metabolic disorders. Cells. 2018;7:63.
Sitsel A, de Raeymaecker J, Drachmann ND, Derua R, Smaardijk S, Andersen JL, et al. Structures of the heart specific SERCA2a Ca2+‐ATPase. EMBO J. 2019;38:e100020.
Tkacz JS, Lampen JO. Tunicamycin inhibition of polyisoprenyl N‐acetylglucosaminyl pyrophosphate formation in calf‐liver microsomes. Biochem Biophys Res Commun. 1975;65:248–257.
Lehle L, Tanner W. The specific site of tunicamycin inhibition in the formation of dolichol‐bound N‐acetylglucosamine derivatives. FEBS Lett. 1976;71:167–170.
Štambuk T, Kifer D, Greto VL, Dempster NJ, Cvetko A, Gillies RS, et al. Alterations in plasma protein N‐glycosylation after caloric restriction and bariatric surgery. Surg Obes Relat Dis. 2024;20:587–596.
Meissner JM, Chmielińska A, Ofri R, Cisło‐Sankowska A, Marycz K. Extracellular vesicles isolated from equine adipose‐derived stromal stem cells (ASCs) mitigate tunicamycin‐induced ER stress in equine corneal stromal stem cells (CSSCs). Curr Issues Mol Biol. 2024;46:3251–3277.
Walters B, Trumble TN, Wendt‐Hornickle E, Kennedy M, Guedes AGP. Effects of cyclooxygenase and soluble epoxide hydrolase inhibitors on apoptosis of cultured primary equine chondrocytes. Res Vet Sci. 2022;147:44–49.
Faleiros R, Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, et al. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res. 2004;65:578–585.
Karikoski N, Karikoski NP, Patterson‐Kane JC, Asplin KE, McGowan T, McNutt M, et al. Morphological and cellular changes in secondary epidermal laminae of horses with insulin‐induced laminitis. Am J Vet Res. 2014;75:161–168.
Dern K, van Eps A, Wittum T, Watts M, Pollitt C, Belknap J. Effect of continuous digital hypothermia on lamellar inflammatory signaling when applied at a clinically‐relevant timepoint in the oligofructose laminitis model. J Vet Intern Med. 2018;32:450–458.
Leise BS, Faleiros R, Watts MR, Johnson P, Black S, Belknap JK. Laminar inflammatory gene expression in the carbohydrate overload model of equine laminitis. Equine Vet J. 2011;43:54–61.
Visser MB, Pollitt CC. Lamellar leukocyte infiltration and involvement of IL‐6 during oligofructose‐induced equine laminitis development. Vet Immunol Immunopathol. 2011;144:120–128.
Tadros EM, Frank N, Horohov DW. Inflammatory cytokine gene expression in blood during the development of oligofructose‐induced laminitis in horses. J Equine Vet Sci. 2013;33:802–808.
Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023;20:217–251.
Storms N, de la Rebière G, Franck T, Mouithys Mickalad A, Sandersen C, Ceusters J, et al. Neutrophil extracellular traps and active myeloperoxidase concentrate in lamellar tissue of equids with naturally occurring laminitis. Vet Immunol Immunopathol. 2024;270:110738.
Yamauchi T, Iwabu M, Okada‐Iwabu M, Kadowaki T. Adiponectin receptors: a review of their structure, function and how they work. Best Pract Res Clin Endocrinol Metab. 2014;28:15–23.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–451.
van Andel M, Heijboer AC, Drent ML. Adiponectin and its isoforms in pathophysiology. Advances in clinical chemistry. Volume 85. London: Academic Press; 2018. p. 115–147.
Guo J, Bian Y, Bai R, Li H, Fu M, Xiao C. Globular adiponectin attenuates myocardial ischemia/reperfusion injury by upregulating endoplasmic reticulum Ca2+‐Atpase activity and inhibiting endoplasmic reticulum stress. J Cardiovasc Pharmacol. 2013;62:143–153.
Iwabu M, Yamauchi T, Okada‐Iwabu M, Sato K, Nakagawa T, Funata M, et al. Adiponectin and AdipoR1 regulate PGC‐1α and mitochondria by Ca2+ and AMPK/SIRT1. Nature. 2010;464:1313–1319.
Parker‐Duffen JL, Nakamura K, Silver M, Kikuchi R, Tigges U, Yoshida S, et al. T‐cadherin is essential for adiponectin‐mediated revascularization. J Biol Chem. 2013;288:24886–24897.
Kita S, Fukuda S, Maeda N, Shimomura I. Native adiponectin in serum binds to mammalian cells expressing t‐cadherin, but not adipors or calreticulin. Elife. 2019;8:8.
Peng H, Wang J, Chen J, Peng Y, Wang X, Chen Y, et al. Challenges and opportunities in delivering oral peptides and proteins. Expert Opin Drug Deliv. 2023;20:1349–1369.
Nie L, He K, Wu W, Zhang H, Gao C, Xiong B, et al. AdipoRon attenuates steatosis, inflammation and fibrosis in murine diet‐induced NASH via inhibiting ER stress. Diabetes Obes Metab. 2025;27:4950–4967.
Salmons HI, Gow C, Limberg AK, Bettencourt JW, Carstens MF, Payne AN, et al. The safety of adiponectin receptor agonist AdipoRon in a rabbit model of arthrofibrosis. Tissue Eng Part C Methods. 2023;29:154–159.
Tan W, Jiang K, Zhang Y, Gao H, Tang X, Jiang S. Adiponectin receptor agonist reduces broiler hepatic lipid deposition. Front Vet Sci. 2025;12:12.
Qiu W, Wu H, Hu Z, Wu X, Tu M, Fang F, et al. Identification and characterization of a novel adiponectin receptor agonist adipo anti‐inflammation agonist and its anti‐inflammatory effects in vitro and in vivo. Br J Pharmacol. 2021;178:280–297.
Wang Y, Wu Z, Li D, Wang D, Wang X, Feng X, et al. Involvement of oxygen‐regulated protein 150 in AMP‐activated protein kinase‐mediated alleviation of lipid‐induced endoplasmic reticulum stress. J Biol Chem. 2011;286:11119–11131.
Zineldeen DH, Tahoon NM, Sarhan NI. AICAR ameliorates non‐alcoholic fatty liver disease via modulation of the HGF/NF‐κB/SNARK signaling pathway and restores mitochondrial and endoplasmic reticular impairments in high‐fat diet‐fed rats. Int J Mol Sci. 2023;24:3367.
Boß M, Newbatt Y, Gupta S, Collins I, Brüne B, Namgaladze D. AMPK‐independent inhibition of human macrophage ER stress response by AICAR. Sci Rep. 2016;6:6.
Burns TA, Watts MR, Weber PS, McCutcheon LJ, Geor RJ, Belknap JK. Effect of dietary nonstructural carbohydrate content on activation of 5′‐adenosine monophosphate‐activated protein kinase in liver, skeletal muscle, and digital laminae of lean and obese ponies. J Vet Intern Med. 2014;28:1280–1288.
Liu C, Yan DY, Wang C, Ma Z, Deng Y, Liu W, et al. Manganese activates autophagy to alleviate endoplasmic reticulum stress‐induced apoptosis via PERK pathway. J Cell Mol Med. 2020;24:328–341.